Cytogenetic profile of 1791 adult acute myeloid leukemia in India

[1]  E. Mosad,et al.  Cytogenetic profile of adult acute myeloid leukemia in Egypt: a single-center experience , 2022, Molecular Cytogenetics.

[2]  B. Ebert,et al.  Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. , 2022, Blood.

[3]  M. Loh,et al.  International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. , 2022, Blood.

[4]  Y. Natkunam,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[5]  J. Eswaran,et al.  Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from Malaysia , 2021, International journal of molecular sciences.

[6]  Matthew P Wright,et al.  Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management , 2020 .

[7]  M. Rachid,et al.  Cytogenetic profile of a representative cohort of young adults with de novo acute myéloblastic leukaemia in Morocco. , 2019, Cancer genetics.

[8]  M. S. Shaikh,et al.  Distribution of Chromosomal Abnormalities Commonly Observed in Adult Acute Myeloid Leukemia in Pakistan as Predictors of Prognosis , 2018, Asian Pacific journal of cancer prevention : APJCP.

[9]  J. Tchinda,et al.  Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups , 2016, Cancer.

[10]  S. Gujral,et al.  Cytogenetic Profile in 7209 Indian Patients with de novo Acute Leukemia: A Single Centre Study from India , 2016 .

[11]  Jinny Park,et al.  Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study , 2016, Annals of Hematology.

[12]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[13]  B. George,et al.  Acute myeloid leukaemia: challenges and real world data from India , 2015, British journal of haematology.

[14]  B. Johansson,et al.  Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience , 2014, Blood Cancer Journal.

[15]  Z. Zakaria,et al.  Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia , 2013, International journal of biomedical science : IJBS.

[16]  Wei Liu,et al.  Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia. , 2012, Blood cells, molecules & diseases.

[17]  A. Jankowska,et al.  Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Saâd,et al.  Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia , 2012, Hematology.

[19]  W. Choi,et al.  A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia--evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients. , 2011, Cancer genetics.

[20]  B. Löwenberg,et al.  Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum , 2011, Haematologica.

[21]  F. Appelbaum,et al.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. , 2010, Blood.

[22]  L. Arenillas,et al.  Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia? , 2010, Leukemia research.

[23]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[24]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[25]  M. Lin,et al.  Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China , 2009, Leukemia.

[26]  T. Naoe,et al.  Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol , 2008, International journal of hematology.

[27]  M. Braekeleer,et al.  Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML , 2007, European journal of haematology.

[28]  M. Odero,et al.  Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. , 2006, Leukemia research.

[29]  S. Ogston,et al.  Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia , 2006, Leukemia.

[30]  W. Hiddemann,et al.  Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients , 2005, Annals of Hematology.

[31]  C. Vallejos,et al.  Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARα fusion gene , 2003, British journal of haematology.

[32]  B. Swolin,et al.  Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. , 2003, Cancer genetics and cytogenetics.

[33]  P. Cin.  Metaphase Harvest and Cytogenetic Analysis of Malignant Hematological Specimens , 2003 .

[34]  N. Harris,et al.  The World Health Organization (WHO) classification of the myeloid neoplasms. , 2002, Blood.

[35]  C. Bloomfield,et al.  Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). , 2002, Blood.

[36]  C. Bloomfield,et al.  Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q , 2002, Genes, chromosomes & cancer.

[37]  F. Speleman,et al.  Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using m‐FISH , 2002, Genes, chromosomes & cancer.

[38]  G. Morgan,et al.  Karyotype and age in acute myeloid leukemia. Are they linked? , 2001, Cancer genetics and cytogenetics.

[39]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  K. Lakshmaiah,et al.  Clinical profile, cytogenetics and treatment outcomes of adult acute myeloid leukemia. , 2020, Journal of Cancer Research and Therapeutics.

[41]  A. Enjeti,et al.  Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity - a single center study from Singapore. , 2004, The hematology journal : the official journal of the European Haematology Association.

[42]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[43]  K. Byth,et al.  Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases , 2000, Leukemia.

[44]  B. Bellosillo,et al.  Lymphoma: A Single Disease With Multiple Variants , 1999 .

[45]  R. Brunning,et al.  The World Health Organization (who) Classification of the Myeloid Neoplasms , 2022 .